Clinical Trial for Advanced Bile Duct Cancer
0 vistas
• 07/01/23
0
0
Empotrar
administrator
Suscriptores
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios